BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27712765)

  • 1. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Kowalski ML; Wardzyńska A; Makowska JS
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
    Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
    Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin sensitivity: implications for patients with coronary artery disease.
    Gollapudi RR; Teirstein PS; Stevenson DD; Simon RA
    JAMA; 2004 Dec; 292(24):3017-23. PubMed ID: 15613671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
    Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
    J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Cohn JR
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):196; author reply 196-7. PubMed ID: 17718110
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergy and intolerance to nonsteroidal antinflammatory drugs: successful desensitization in three cases].
    Cardona R; Ramírez RH; Reina Z; Escobar MF; Morales E
    Biomedica; 2009 Jun; 29(2):181-90. PubMed ID: 20128343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease.
    Tajudeen BA; Schwartz JS; Bosso JV
    Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):30-34. PubMed ID: 27849653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.
    White AA; Bosso JV; Stevenson DD
    Allergy Asthma Proc; 2013; 34(4):378-382. PubMed ID: 23883603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
    Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
    Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
    HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
    Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
    J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA; Dazy KM; Waldram JD
    Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to nonsteroidal anti-inflammatory drugs.
    Namazy JA; Simon RA
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.